Cargando…

The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses

Background: Disease modifying therapy (DMT) efficacy trials make an essential contribution to the development of evidence-based clinical treatments and practices for people with multiple sclerosis (MS). Meta-analysis is a critical part of this process and provides a powerful tool to assess the effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Claflin, Suzi B., Broadley, Simon, Taylor, Bruce V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335290/ https://www.ncbi.nlm.nih.gov/pubmed/30687214 http://dx.doi.org/10.3389/fneur.2018.01150

Ejemplares similares

Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset
por: Tao, Chunrong, et al.
Publicado: (2018)

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2020)

Building a Successful Massive Open Online Course About Multiple Sclerosis: A Process Description
por: Claflin, Suzi B, et al.
Publicado: (2020)

Multimodal diagnostics in multiple sclerosis: predicting disability and conversion from relapsing-remitting to secondary progressive disease course – protocol for systematic review and meta-analysis
por: Statsenko, Yauhen, et al.
Publicado: (2023)

Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis
por: Blok, Katelijn M., et al.
Publicado: (2023)

Disease Activity and Progression of Disability in Multiple Sclerosis Patients Aged Over 50 With or Without Disease-Modifying Drug Treatment: A Retrospective Cohort Study
por: Kondo, Akihiro, et al.
Publicado: (2023)

Factors Influencing the Degree of Disability in Patients With Multiple Sclerosis
por: Xue, Huiru, et al.
Publicado: (2021)

Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review
por: Zarghami, Amin, et al.
Publicado: (2022)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

An Overview of the History, Pathophysiology, and Pharmacological Interventions of Multiple Sclerosis
por: Dighriri, Ibrahim M, et al.
Publicado: (2023)

Systematic Review of the Socioeconomic Consequences in Patients With Multiple Sclerosis With Different Levels of Disability and Cognitive Function
por: Kavaliunas, Andrius, et al.
Publicado: (2022)

Deciphering Multiple Sclerosis Progression
por: Meca-Lallana, Virginia, et al.
Publicado: (2021)

Evaluating Course Completion, Appropriateness, and Burden in the Understanding Multiple Sclerosis Massive Open Online Course: Cohort Study
por: Claflin, Suzi B, et al.
Publicado: (2021)

An Overview of Venous Abnormalities Related to the Development of Lesions in Multiple Sclerosis
por: Haacke, E. Mark, et al.
Publicado: (2021)

Measurement Properties of the Health Literacy Questionnaire in the Understanding Multiple Sclerosis Massive Open Online Course Cohort: A Rasch Analysis
por: Bessing, Barnabas, et al.
Publicado: (2022)

Editorial: Disease modifying therapies in multiple sclerosis
por: Bonavita, Simona, et al.
Publicado: (2022)

The Contribution of Various MRI Parameters to Clinical and Cognitive Disability in Multiple Sclerosis
por: Tóth, Eszter, et al.
Publicado: (2019)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial
por: Urbi, Berzenn, et al.
Publicado: (2019)

Development and Internal Validation of a Disability Algorithm for Multiple Sclerosis in Administrative Data
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Clinical Profile and the Extent of Disability in Multiple Sclerosis Patients in Madinah, Saudi Arabia
por: Alsaedi, Esraa Q, et al.
Publicado: (2022)

How is neuromuscular fatigability affected by perceived fatigue and disability in people with multiple sclerosis?
por: Royer, Nicolas, et al.
Publicado: (2022)

Memantine for Multiple Sclerosis: A Systematic Review and Meta-Analysis of Randomized Trials
por: Turalde, Christian Wilson R., et al.
Publicado: (2021)

Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies
por: Simone, Isabella Laura, et al.
Publicado: (2021)

Smartphone Level Test Measures Disability in Several Neurological Domains for Patients With Multiple Sclerosis
por: Boukhvalova, Alexandra K., et al.
Publicado: (2019)

A Comprehensive Approach to Disentangle the Effect of Cerebellar Damage on Physical Disability in Multiple Sclerosis
por: Ruggieri, Serena, et al.
Publicado: (2020)

Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing–remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis
por: Lees, Samuel, et al.
Publicado: (2021)

Vision and Vision-Related Measures in Progressive Multiple Sclerosis
por: Backner, Yael, et al.
Publicado: (2019)

The Role of B Cells in Primary Progressive Multiple Sclerosis
por: Holloman, Jameson P., et al.
Publicado: (2021)

Multiple sclerosis and exercise—A disease-modifying intervention of mice or men?
por: Martin, Sarah-Jane, et al.
Publicado: (2023)

Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis
por: Andelova, Michaela, et al.
Publicado: (2019)

Retrospective cohort study of the relationship between systolic blood pressure variability and multiple sclerosis disability
por: Goldman, Myla D, et al.
Publicado: (2020)

Migraine and Medical Ramifications: A Comprehensive Overview Based on Observational Study Meta-Analyses
por: Chen, Weiwei, et al.
Publicado: (2021)

Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review
por: Krajnc, Nik, et al.
Publicado: (2021)

Pharmacogenomics of Multiple Sclerosis: A Systematic Review
por: Hočevar, Keli, et al.
Publicado: (2019)

Sex-Specific Environmental Impacts on Initiation and Progression of Multiple Sclerosis
por: Leffler, Jonatan, et al.
Publicado: (2022)

Consensus on early detection of disease progression in patients with multiple sclerosis
por: Meca-Lallana, José E., et al.
Publicado: (2022)

Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review
por: Capone, Fioravante, et al.
Publicado: (2022)

Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies
por: Simoens, Steven
Publicado: (2022)

Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a systematic review and meta-analysis
por: Yang, Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jqo6obr4l01ujbniuleetov1tc